/PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), a leading innovator in cannabinoid and.
/PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), a leading innovator in cannabinoid and.
TORONTO, Jan. 10, 2022 /PRNewswire/ - Canntab Therapeutics Limited , a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is. | January 10, 2022